Provided by Tiger Trade Technology Pte. Ltd.

DEFIANCE DAILY TARGET 2X LONG HIMS ETF

26.07
-0.4700-1.77%
Post-market: 26.120.0500+0.19%19:56 EDT
Volume:405.18K
Turnover:10.96M
Market Cap:53.17M
PE:- -
High:28.97
Open:27.86
Low:25.20
Close:26.54
52wk High:391.58
52wk Low:12.38
Shares:2.04M
Float Shares:2.04M
Volume Ratio:1.60
T/O Rate:19.87%
Dividend:1.98
Dividend Rate:7.59%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Is New Regional CMOs Altering The Investment Case For Hims & Hers Stock (HIMS)?

Simply Wall St.
·
Yesterday

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,461 Common Shares Worth $100,964.37

Reuters
·
Yesterday

Hims & Hers Names Kultar Garcha UK and EMEA Chief Medical Officer

Reuters
·
Oct 01

Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening Its Investment in Local Clinical Leadership

THOMSON REUTERS
·
Oct 01

Hims & Hers Health, - Appoints Kultar Garcha as Chief Medical Officer UK and Emea; Matt Vickers as Chief Medical Officer Australia

THOMSON REUTERS
·
Oct 01

ETF Daily | FOMG Soars 19%; CBRZ Jumps 18%; BEZ Climbs 10%; JBLG Plunges 21%; Inverse Equity Funds Lead

ETF Tracker
·
Oct 01

Hims & Hers CFO Oluyemi Okupe Sells 29,277 Common Shares for $876,846.15

Reuters
·
Sep 24

Cboe data suggests bullish flow in Hims and Hers Health with shares up 3.56%

TIPRANKS
·
Sep 23

100 Million UUSD Tokens Debut on Robinhood Chain as Tokenized Equity Push Accelerates

Stock News
·
Sep 21

Hims & Hers CTO Mohamed Elshenawy Sells 7,954 Shares Worth $225,421.06

Reuters
·
Sep 18

Moderately bullish activity in Hims and Hers Health with shares up 0.47%

TIPRANKS
·
Sep 17

Bank of America Securities Sticks to Its Hold Rating for Hims & Hers Health (HIMS)

TIPRANKS
·
Sep 15

Hims & Hers Health Price Target Announced at $32.00/Share by JP Morgan

Dow Jones
·
Sep 11

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,458 Common Shares for $97,961.14

Reuters
·
Sep 04

Analysts Have Conflicting Sentiments on These Healthcare Companies: Hims & Hers Health (HIMS) and Oxford BioMedica (OtherOXBDF)

TIPRANKS
·
Sep 02

Hims & Hers Health Enters Australia, Marks First Asia-Pacific Market Presence

Reuters
·
Sep 01

Hims & Hers Enters Australia in First Asia-Pacific Expansion

Reuters
·
Sep 01

Hims & Hers Offers GLP-1 Weight-Loss Drugs, Men's Health Treatments in Australia

Reuters
·
Sep 01

How GLP-1 Sales Could Play Out for Hims & Hers

Dow Jones
·
Aug 26

Truist Securities Adjusts Price Target on Hims & Hers Health to $32 From $27, Keeps Hold Rating

MT Newswires Live
·
Aug 25